New Haven’s biotech community has seen fits and starts, but today it is achieving critical mass. Upwards of 50 biotech and medical device companies employ more than 5,000 people in greater New Haven. Venture capital firms and large pharmaceutical companies have invested more than $700 million in startups. Yale, the state, and the city have established programs aimed at helping student and faculty inventors become entrepreneurs. And New Haven itself has become a more attractive place for young scientists and engineers to live.
At the center of these efforts is Craig Crews, PhD, the Lewis B. Cullman Professor of Molecular, Cellular and Developmental Biology, with appointments in the departments of chemistry and pharmacology. He is not only a leading medical science researcher, but also an entrepreneur. Arvinas, the company he started four years ago, uses ideas from his lab to develop therapies for treating cancer. Crews also helps other Yale researchers—and their inventions—make the journey from the lab to the marketplace.
For more on this story, please visit Yale School of Medicine News.